- 
        
                            
                GoodRx Holdings Inc. (GDRX $3.31)
    
        - $3.31 P/E (TTM): 34.74X Cap: $1.22B
 - View GDRX Profile
 - View Questions on GDRX
 
 
Detailed Quote
                     Questions on this company?
                                    Become a Member
                                                            Company Profile
                    {tplLang.businessdescription | toLang tLang}
                                    { profileData.description }
                                    
{tplLang.details | toLang tLang}
{tplLang.ceo | toLang tLang}
                                    {profileData.profile.details.ceo}
                                    {tplLang.employees | toLang tLang}
                                    {profileData.profile.details.employees | numeraljs '0,0'}
                                    {tplLang.issuetype | toLang tLang}
                                    {profileData.profile.details.issuetype | asIssueType}
                                    {tplLang.industryclassifications | toLang tLang}
{tplLang.sector | toLang tLang}
                                    {profileData.profile.classification.sector}
                                    {tplLang.industry | toLang tLang}
                                    {profileData.profile.classification.industry}
                                    {tplLang.toolname| toLang tLang}
There is no {tplLang.toolname| toLang tLang} currently available for
                                            {data.symbolstring}.
                                    
                                    Interactive Chart
            Key Ratios
            Earnings
            Analyst Recommendations
                    5i Recent Questions
                            - 
        
                            
                GoodRx Holdings Inc. (GDRX $3.31)
    
        - $3.31 P/E (TTM): 34.74X Cap: $1.22B
 - View GDRX Profile
 - View Questions on GDRX
 
 
            Q: I've reviewed past Q&A on your website re: GDRX; also their investor newsletter released with the Q4 and Annual results. Do you see value over the next 5 years after today's strong drop (-38.9%) given it's competitors, revenue growth still reasonably robust, and adj net income and EBITDA that is + and growing?
        
    - 
        
                            
                GoodRx Holdings Inc. (GDRX $3.31)
    
        - $3.31 P/E (TTM): 34.74X Cap: $1.22B
 - View GDRX Profile
 - View Questions on GDRX
 
 
            Q: GDRX What are your current thoughts on this company?  Would it be a buy at this level?  Thanks
        
    - 
        
                            
                Clean Energy Fuels Corp. (CLNE $2.89)
    
        - $2.89 Cap: $627M
 - View CLNE Profile
 - View Questions on CLNE
 
 - 
        
                            
                Boston Omaha Corporation Class A (BOMN)
    
        - P/E (TTM): 8.0X Cap: $763M
 - View BOMN Profile
 - View Questions on BOMN
 
 - 
        
                            
                Twist Bioscience Corporation (TWST $31.57)
    
        - $31.57 Cap: $1.98B
 - View TWST Profile
 - View Questions on TWST
 
 - 
        
                            
                Butterfly Network Inc Cl A (LGVW)
    
        - P/E (TTM): -3021.0X Cap: $1.19B
 - View LGVW Profile
 - View Questions on LGVW
 
 - 
        
                            
                GoodRx Holdings Inc. (GDRX $3.31)
    
        - $3.31 P/E (TTM): 34.74X Cap: $1.22B
 - View GDRX Profile
 - View Questions on GDRX
 
 - 
        
                            
                QuantumScape Corporation Class A (QS $16.21)
    
        - $16.21 Cap: $9.74B
 - View QS Profile
 - View Questions on QS
 
 
            Q: I watched a presentation on Saturday where analysts fielded audience company suggestions and whittled them down to a few that they felt could 10 X in a reasonable time frame.  I am wondering if you can look at this six and rank based on potential?  For the top two, it would be great if you can discuss the TAM, impact of market value and shares outstanding, if they are solving a new problem/creating a new market and quality of management.  Basically, why those two?
Longview Acquisition Corp
Good RX
Boston Omaha
Quantumscape
Clean Energy Services
Twist Biosciences
    Longview Acquisition Corp
Good RX
Boston Omaha
Quantumscape
Clean Energy Services
Twist Biosciences
Insiders
                    Share Information
                    SEC Filings
                        News and Media